Personalis, Inc. (NASDAQ:PSNL) Q1 2026 Earnings Call Transcript
Operator: Greetings, and welcome to the Personalis, Inc. First Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Personalis Inc. (PSNL)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 1,715,000 | $22,981,000 | -41% | 1.45% |
| 2. | Winton Capital Management David Harding | 37,013 | $495,974 | 0.02% | |
| 3. | Persistent Asset Partners Xin Huang | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.93 | 28,000 | $250,040.00 | 13,039,067 | 2025-12-22 | Filing | |
| $8.39 | 29,641 | $248,687.99 | 13,011,067 | 2025-12-19 | Filing | |
| $7.91 | 31,430 | $248,611.30 | 12,981,426 | 2025-12-18 | Filing | |
| $7.86 | 31,650 | $248,769.00 | 12,949,996 | 2025-12-17 | Filing | |
| $11.00 | 13,888 | $152,768.00 | 12,918,346 | 2025-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.15 | 100,000 | $1,515,000.00 | 173,880 | 2026-07-15 | Filing | |
| $15.08 | 100,000 | $1,508,000.00 | 235,986 | 2026-07-09 | Filing | |
| $14.00 | 4,982 | $69,748.00 | 198,833 | 2026-06-29 | Filing | |
| $13.18 | 51,251 | $675,488.18 | 198,833 | 2026-06-26 | Filing | |
| $13.15 | 100,000 | $1,315,000.00 | 235,986 | 2026-06-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,044,943 | $188,202,236 | 35.75% | |
| 2. | 7,082,491 | $94,905,378 | 0% | |
| 3. | 3,747,290 | $50,213,686 | 0.07% | |
| 4. | 1,487,077 | $19,926,832 | 0% | |
| 5. | 555,641 | $7,445,590 | 0.27% |
News See All
10 Best Diagnostics and Research Stocks to Buy According to Analysts
The diagnostics and research sector holds a crucial position in the healthcare ecosystem, thus attracting investor interest.
Personalis, Inc. (NASDAQ:PSNL) Q4 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Personalis Fourth Quarter 2025 Earnings Conference. [Operator Instructions] As a reminder, this conference is being recorded.
Personalis, Inc. (PSNL): A Bull Case Theory
We came across a bullish thesis on Personalis, Inc. on Adventures in Burning & Compounding’s Substack by Rush. In this article, we will summarize the bulls’ thesis on PSNL.
Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)
The Fly reported on December 2, 2025, that Morgan Stanley analyst Kallum Titchmarsh took over coverage of Personalis, Inc.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
Personalis, Inc. (NASDAQ:PSNL) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Personalis Third Quarter 2025 Earnings Conference. [Operator Instructions] Please note that this event is being recorded.
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings, and welcome to the Personalis Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the Personalis's First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.